Morpholino

MO5-birc5b

ID

ZDB-MRPHLNO-101105-3

Name

MO5-birc5b

Previous Names

Target

Sequence

5' - CGCCATCTGAGGACAAGATTCACAC - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

Splice-blocking MO.

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO5-birc5b

Expressed Gene	Anatomy	Figures
egr2b	rhombomere 3 rhombomere 5	Fig. 5 from Ma et al., 2009
gata1a	erythroid lineage cell	Fig. 5 from Ma et al., 2009
hbae1.1	erythroid lineage cell	Fig. 5 from Ma et al., 2009
hbbe1.1	erythroid lineage cell	Fig. 5 from Ma et al., 2009
lcp1	granulocyte monocyte progenitor cell	Fig. 5 from Ma et al., 2009
lmo2	angioblastic mesenchymal cell	Fig. 5 from Ma et al., 2009
neurog1	forebrain hindbrain midbrain spinal cord neural tube	Fig. 5 from Ma et al., 2009
pax2a	midbrain hindbrain boundary optic stalk otic vesicle	Fig. 5 from Ma et al., 2009
spi1b	granulocyte monocyte progenitor cell	Fig. 5 from Ma et al., 2009
tal1	angioblastic mesenchymal cell	Fig. 5 from Ma et al., 2009

Phenotype

Phenotype resulting from MO5-birc5b

Phenotype	Fish	Figures
apoptotic process increased occurrence, abnormal	WT + MO5-birc5b	Fig. 6 from Ma et al., 2009
blood circulation decreased occurrence, abnormal	WT + MO5-birc5b	Fig. 4 from Ma et al., 2009
embryonic camera-type eye development delayed, abnormal	WT + MO5-birc5b	Fig. 3 from Ma et al., 2009
erythroid lineage cell decreased amount, abnormal	la781Tg + MO5-birc5b	Fig. 4, Fig. 6 from Ma et al., 2009
head development delayed, abnormal	WT + MO5-birc5b	Fig. 3 from Ma et al., 2009
intermediate cell mass of mesoderm apoptotic, abnormal	la781Tg + MO5-birc5b	Fig. 6 from Ma et al., 2009
primitive hemopoiesis disrupted, abnormal	la781Tg + MO5-birc5b	Fig. 4 from Ma et al., 2009

Phenotype of all Fish created by or utilizing MO5-birc5b

Phenotype	Fish	Conditions	Figures
embryonic camera-type eye development delayed, abnormal	WT + MO5-birc5b	standard conditions	Fig. 3 from Ma et al., 2009
head development delayed, abnormal	WT + MO5-birc5b	standard conditions	Fig. 3 from Ma et al., 2009
intermediate cell mass of mesoderm apoptotic, abnormal	WT + MO5-birc5b	standard conditions	Fig. 6 from Ma et al., 2009
blood circulation decreased occurrence, abnormal	WT + MO5-birc5b	standard conditions	Fig. 4 from Ma et al., 2009
apoptotic process increased occurrence, abnormal	WT + MO5-birc5b	standard conditions	Fig. 6 from Ma et al., 2009
primitive hemopoiesis disrupted, abnormal	la781Tg + MO5-birc5b	standard conditions	Fig. 4 from Ma et al., 2009
intermediate cell mass of mesoderm apoptotic, abnormal	la781Tg + MO5-birc5b	standard conditions	Fig. 6 from Ma et al., 2009
erythroid lineage cell decreased amount, abnormal	la781Tg + MO5-birc5b	standard conditions	Fig. 4, Fig. 6 from Ma et al., 2009

Citations